672 related articles for article (PubMed ID: 34809540)
1. Theranostic Applications of Nanomaterials in Alzheimer's Disease: A Multifunctional Approach.
Tripathi P; Shukla P; Bieberich E
Curr Pharm Des; 2022; 28(2):116-132. PubMed ID: 34809540
[TBL] [Abstract][Full Text] [Related]
2. The application of multifunctional nanomaterials in Alzheimer's disease: A potential theranostics strategy.
Xu Y; Zhao M; Zhou D; Zheng T; Zhang H
Biomed Pharmacother; 2021 May; 137():111360. PubMed ID: 33582451
[TBL] [Abstract][Full Text] [Related]
3. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
4. Advancements in Applications of Surface Modified Nanomaterials for Cancer Theranostics.
Ahmad IZ; Kuddus M; Tabassum H; Ahmad A; Mabood A
Curr Drug Metab; 2017; 18(11):983-999. PubMed ID: 28969548
[TBL] [Abstract][Full Text] [Related]
5. Quantum dots as a theranostic approach in Alzheimer's disease: a systematic review.
Villalva MD; Agarwal V; Ulanova M; Sachdev PS; Braidy N
Nanomedicine (Lond); 2021 Aug; 16(18):1595-1611. PubMed ID: 34180261
[No Abstract] [Full Text] [Related]
6. Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.
Ahmad J; Akhter S; Rizwanullah M; Khan MA; Pigeon L; Addo RT; Greig NH; Midoux P; Pichon C; Kamal MA
Curr Alzheimer Res; 2017; 14(11):1164-1181. PubMed ID: 28482786
[TBL] [Abstract][Full Text] [Related]
7. Theranostic applications of nanoparticles in neurodegenerative disorders.
Ramanathan S; Archunan G; Sivakumar M; Tamil Selvan S; Fred AL; Kumar S; Gulyás B; Padmanabhan P
Int J Nanomedicine; 2018; 13():5561-5576. PubMed ID: 30271147
[TBL] [Abstract][Full Text] [Related]
8. Multifunctional nanomedicine with silica: Role of silica in nanoparticles for theranostic, imaging, and drug monitoring.
Chen F; Hableel G; Zhao ER; Jokerst JV
J Colloid Interface Sci; 2018 Jul; 521():261-279. PubMed ID: 29510868
[TBL] [Abstract][Full Text] [Related]
9. Engineered Hybrid Nanoparticles for On-Demand Diagnostics and Therapeutics.
Nguyen KT; Zhao Y
Acc Chem Res; 2015 Dec; 48(12):3016-25. PubMed ID: 26605438
[TBL] [Abstract][Full Text] [Related]
10. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine.
Moorthy H; Govindaraju T
ACS Appl Bio Mater; 2021 Feb; 4(2):1115-1139. PubMed ID: 35014470
[TBL] [Abstract][Full Text] [Related]
11. An Assessment of In-vitro and In-vivo Evaluation Methods for Theranostic Nanomaterials.
Parashar P; Singh N; Alka ; Maurya P; Saraf SA
Curr Pharm Des; 2022; 28(2):78-90. PubMed ID: 34348616
[TBL] [Abstract][Full Text] [Related]
12. Receptor-Targeted Surface-Engineered Nanomaterials for Breast Cancer Imaging and Theranostic Applications.
Ahmad J; Rizwanullah M; Suthar T; Albarqi HA; Ahmad MZ; Vuddanda PR; Khan MA; Jain K
Crit Rev Ther Drug Carrier Syst; 2022; 39(6):1-44. PubMed ID: 35997100
[TBL] [Abstract][Full Text] [Related]
13. Nanoparticle-Based Technology Approaches to the Management of Neurological Disorders.
Sim TM; Tarini D; Dheen ST; Bay BH; Srinivasan DK
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842530
[TBL] [Abstract][Full Text] [Related]
14. Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging.
Bhaskar S; Tian F; Stoeger T; Kreyling W; de la Fuente JM; Grazú V; Borm P; Estrada G; Ntziachristos V; Razansky D
Part Fibre Toxicol; 2010 Mar; 7():3. PubMed ID: 20199661
[TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Theranostic Applications of Nanomaterials in Cancer.
Ahmed F; Khan MA; Haider N; Ahmad MZ; Ahmad J
Curr Pharm Des; 2022; 28(2):133-150. PubMed ID: 34530703
[TBL] [Abstract][Full Text] [Related]
16. Review of Current Strategies for Delivering Alzheimer's Disease Drugs across the Blood-Brain Barrier.
Wong KH; Riaz MK; Xie Y; Zhang X; Liu Q; Chen H; Bian Z; Chen X; Lu A; Yang Z
Int J Mol Sci; 2019 Jan; 20(2):. PubMed ID: 30658419
[TBL] [Abstract][Full Text] [Related]
17. Recent Trends and Developments in Multifunctional Nanoparticles for Cancer Theranostics.
Rabaan AA; Bukhamsin R; AlSaihati H; Alshamrani SA; AlSihati J; Al-Afghani HM; Alsubki RA; Abuzaid AA; Al-Abdulhadi S; Aldawood Y; Alsaleh AA; Alhashem YN; Almatouq JA; Emran TB; Al-Ahmed SH; Nainu F; Mohapatra RK
Molecules; 2022 Dec; 27(24):. PubMed ID: 36557793
[TBL] [Abstract][Full Text] [Related]
18. Versatile nanomaterials for Alzheimer's disease: Pathogenesis inspired disease-modifying therapy.
Xi Y; Chen Y; Jin Y; Han G; Song M; Song T; Shi Y; Tao L; Huang Z; Zhou J; Ding Y; Zhang H
J Control Release; 2022 May; 345():38-61. PubMed ID: 35257810
[TBL] [Abstract][Full Text] [Related]
19. Innovative Therapies and Nanomedicine Applications for the Treatment of Alzheimer's Disease: A State-of-the-Art (2017-2020).
Binda A; Murano C; Rivolta I
Int J Nanomedicine; 2020; 15():6113-6135. PubMed ID: 32884267
[TBL] [Abstract][Full Text] [Related]
20. From Companion Diagnostics to Theranostics: A New Avenue for Alzheimer's Disease?
Bolognesi ML; Gandini A; Prati F; Uliassi E
J Med Chem; 2016 Sep; 59(17):7759-70. PubMed ID: 27124551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
